The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis
Abstract
This study aims to estimate the reliable prevalence of fibromyalgia using meta-analysis method. Available databanks were searched using appropriate keywords. According to the heterogeneity between the results (indicated by Cochrane and I square indices), random- or fixed-effects model was applied to combine the point prevalences. Meta-regression models were used to assess the suspected factors in the heterogeneity. In 65 selected papers, 81 evidences regarding prevalence of fibromyalgia among 3,609,810 subjects from general population and specific groups were investigated. The total prevalences (95% confidence intervals) of fibromyalgia among general population, women, men, patients referring to rheumatology and internal departments, patients with Irritable bowel syndrome (IBS), hemodialysis patients and those with type 2 diabetes mellitus were estimated as of 1.78% (1.65, 1.92), 3.98% (2.80, 5.20), 0.01% (-0.04, 0.06), 15.2% (13.6, 16.90), 12.9% (12.70, 13.10), 6.30% (4.60, 7.90) and 14.80% (11.10, 18.40), respectively. In addition, prevalence of fibromyalgia in specified groups varied from 3.90% in hemodialysis patients to 80% in patients suffering from Behcet syndrome. This meta-analysis showed that prevalence of fibromyalgia in general population was significantly lower than that in populations with some diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“در برخی مطالعات، شیوع فیبرومیالژیا در زنان 6 تا 10 برابر بیشتر از مردان گزارش شده است ] 3 [ .”
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.08.012 · Cited by 2,698
Prevalence of Fibromyalgia: A Survey in Five European Countries
Branco, J. C., Bannwarth, B., Failde, I., Abello Carbonell, J., Blotman, F., Spaeth, M., Saraiva, F., Nacci, F., Thomas, E., Caubère, J.-P., et al. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.12.003 · Cited by 685
Bennett, R. M. (2005) · PubMed · Cited by 616
The prevalence of chronic widespread pain in the general population.
Croft, P. R., Rigby, A. S., Boswell, R., Schollum, J. B. W., & Silman, A. J. (1993) · PubMed · Cited by 474
Jones, G. T., Atzeni, F., Beasley, M., Flüß, E., Sarzi‐Puttini, P., & Macfarlane, G. J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38905 · Cited by 468
Wolfe, F., Brähler, E., Hinz, A., & Häuser, W. (2013) · Arthritis Care & Research · doi:10.1002/acr.21931 · Cited by 443
Vincent, A., Lahr, B. D., Wolfe, F., Clauw, D. J., Whipple, M. O., Oh, T. H., Barton, D. L., & Sauver, J. L. S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21896 · Cited by 385
The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey
Walitt, B., Nahin, R., Katz, R., Bergman, M., & Wolfe, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138024 · Cited by 274
Research works printed but not linked: 1
- Ablin JN, Oren A, Cohen S, Aloush V, Buskila D, Elkayam O et al (2012) Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ). Clin Exp Rheumatol 30(6 Suppl 74):39–43
Cited by
Sorted by citations
Petersen, M. W., Schröder, A., Jørgensen, T., Ørnbøl, E., Meinertz Dantoft, T., Eliasen, M., Benros, M. E., & Fink, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-60318-6 · Cited by 170
Pain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves Prioritization
Casale, R., Atzeni, F., Bazzichi, L., Beretta, G., Costantini, E., Sacerdote, P., & Tassorelli, C. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00244-1 · Cited by 159
“The prevalence of fibromyalgia is eight- to ninefold higher in women than in men [91].”
BackgroundCreed, F. (2020) · Pain · doi:10.1097/j.pain.0000000000001819 · Cited by 135
“Another review reported an increased prevalence of fibromyalgia in patients with other medical disorders including irritable bowel syndrome, diabetes, and patients undergoing haemodialysis.(16) A review concerning the transformation of regional pain to CWP was inconclusive, possibly because it included very few studie…”
BackgroundJurado-Priego, L. N., Cueto‐Ureña, C., Ramírez-Expósito, M. J., & Martínez-Martos, J. M. (2024) · Biomedicines · doi:10.3390/biomedicines12071543 · Cited by 152
The complexities of fibromyalgia and its comorbidities
Lichtenstein, A., Tiosano, S., & Amital, H. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000464 · Cited by 120
Lowry, E., Marley, J., McVeigh, J. G., McSorley, E. M., Allsopp, P. J., & Kerr, D. P. (2020) · Nutrients · doi:10.3390/nu12092664 · Cited by 117
Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis
D'Onghia, M., Ciaffi, J., Lisi, L., Mancarella, L., Ricci, S., Stefanelli, N., Meliconi, R., & Ursini, F. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.02.007 · Cited by 109
Pregabalin as a Pain Therapeutic: Beyond Calcium Channels
Alles, S. R. A., Cain, S. M., & Snutch, T. P. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00083 · Cited by 120
“01% of men reported in the general population (Heidari et al., 2017).”
BackgroundNeurostimulation methods in the treatment of chronic pain
Moisset, X., Lantéri‐Minet, M., & Fontaine, D. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02092-y · Cited by 91
Fibromyalgia Syndrome Pain in Men and Women: A Scoping Review
Ruschak, I., Montesó-Curto, P., Rosselló, L., Aguilar Martín, C., Sánchez-Montesó, L., & Toussaint, L. (2023) · Healthcare · doi:10.3390/healthcare11020223 · Cited by 90
Erdrich, S., Hawrelak, J. A., Myers, S. P., & Harnett, J. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820977402 · Cited by 95
Co-occurrence of pain syndromes
Affaitati, G., Costantini, R., Tana, C., Cipollone, F., & Giamberardino, M. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02107-8 · Cited by 99
Lambourg, E. J., Colvin, L., Guthrie, G. D., Murugan, K., Lim, M., Walker, H., Boon, G., & Bell, S. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.041 · Cited by 85
Häuser, W., Hausteiner‐Wiehle, C., Henningsen, P., Brähler, E., Schmalbach, B., & Wolfe, F. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110111 · Cited by 81
Petersen, M. W., Schröder, A., Jørgensen, T., Ørnbøl, E., Dantoft, T. M., Eliasen, M., Carstensen, T. W., Falgaard Eplov, L., & Fink, P. (2020) · Scandinavian Journal of Public Health · doi:10.1177/1403494819868592 · Cited by 76
“[29] heidari F, Afshari M and Moosazadeh M.”
BackgroundResultDiagnosis and management of sensory polyneuropathy
Gwathmey, K. G., & Pearson, K. (2019) · BMJ · doi:10.1136/bmj.l1108 · Cited by 76
Review article: Physical and psychological comorbidities associated with irritable bowel syndrome
Shiha, M. G., & Aziz, I. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16589 · Cited by 73
Fibromyalgia syndrome: epidemiology, diagnosis and treatment
Koçyiğit, B. F., & Akyol, A. (2022) · Reumatologia/Rheumatology · doi:10.5114/reum.2022.123671 · Cited by 86
Vegetarian and Vegan Diet in Fibromyalgia: A Systematic Review
Nadal-Nicolás, Y., Miralles-Amorós, L., Martínez-Olcina, M., Sánchez-Ortega, M., Mora, J., & Martínez-Rodríguez, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094955 · Cited by 70
“Fibromyalgia (FM) is a chronic non-degenerative disease of unknown etiology without effective medical treatment that mostly affects women [1,2].”
BackgroundPinto, A. M., Luís, M., Geenen, R., Palavra, F., Lumley, M. A., Ablin, J. N., Amris, K., Branco, J., Buskila, D., Castelhano, J., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105235 · Cited by 75
Häuser, W., Brähler, E., Ablin, J. N., & Wolfe, F. (2020) · Arthritis Care & Research · doi:10.1002/acr.24202 · Cited by 61
“Systematic reviews have found the average prevalence of FM in the general population to be 2% (7).”
BackgroundPhysical therapy modalities for treating fibromyalgia
Araújo, F. M., & DeSantana, J. M. (2019) · F1000Research · doi:10.12688/f1000research.17176.1 · Cited by 57
“Fibromyalgia (FM) is a syndrome that affects millions of people around the world (between 0.2 and 6.6% of the world population), especially women, after 50 years of age 1–3 .”
BackgroundInfluentialEffectiveness of multidisciplinary programmes for clinical pain conditions: an umbrella review.
Dragioti, E., Evangelou, E., Larsson, B., & Gerdle, B. (2018) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2377 · Cited by 53
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia
Berger, A. A., Keefe, J., Winnick, A. A., Gilbert, E., Eskander, J. P., Yazdi, C., Kaye, A. D., Viswanath, O., & Urits, I. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.08.010 · Cited by 57
Contribution of Baroreceptor Function to Pain Perception and Perioperative Outcomes
Suárez-Roca, H., Klinger, R. Y., Podgoreanu, M. V., Ji, R., Sigurdsson, M. I., Waldron, N. H., Mathew, J. P., & Maixner, W. D. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002510 · Cited by 52
Groven, N., Reitan, S. K., Fors, E. A., & Güzey, I. C. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105287 · Cited by 49
“Both disorders are common, with prevalence ranging from 0.5% to 2.5% for CFS (Estévez-López et al., 2020) and up to 5% for FM (Heidari et al., 2017).”
BackgroundInfluentialAre the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?
Sarzi‐Puttini, P., Atzeni, F., Masala, I. F., Salaffi, F., Chapman, J., & Choy, E. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.007 · Cited by 48
“AC C EP TE D M AN U SC R IP T than in the case of controls and, as the prevalence of FM is 2-5% [16-18], it can be”
Samartin-Veiga, N., Pidal-Miranda, M., González-Villar, A. J., Bradley, C., García-Larrea, L., O’Brien, A. T., & Carrillo‐de‐la‐Peña, M. T. (2021) · Pain · doi:10.1097/j.pain.0000000000002493 · Cited by 47
Ovrom, E. A., Mostert, K., Khakhkhar, S., McKee, D. P., Yang, P., & Her, Y. F. (2023) · Biomedicines · doi:10.3390/biomedicines11041119 · Cited by 51
“It is estimated that the prevalence of FM in the general population is 2% [5].”
BackgroundOlofsson, T., Wallman, J. K., Jöud, A., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24264 · Cited by 43
“In addition, fibromyalgia is present in up to 25% of RA patients (9,10) (compared to 2% in the general popula tion) (11), lending further support to a multifaceted pain spectrum in RA consisting of both inflammation derived and inflammation independent pain components.”
BackgroundDizner-Golab, A., Lisowska, B., & Kosson, D. (2023) · Reumatologia/Rheumatology · doi:10.5114/reum/163094 · Cited by 59
“Moreover, in the Behçet syndrome group, 80% of the patients developed FM [29].”
BackgroundMethodTuran, K. E., Kocabeyoğlu, S., Ünal-Çevik, I., et al. (2017) · Cornea · doi:10.1097/ico.0000000000001447 · Cited by 40
Non-inflammatory pain in inflammatory arthritis
Das, D., & Choy, E. (2022) · Lara D. Veeken · doi:10.1093/rheumatology/keac671 · Cited by 39
“Heidari et al. (2017) conducted a systematic review of 65 Rheumatology key messages • Fibromyalgia may be secondary to rheumatoid arthritis.”
BackgroundEberhard, A., Bergman, S., Mandl, T., Olofsson, T., Rydholm, M., Jacobsson, L., & Turesson, C. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02550-7 · Cited by 38
Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic Perspectives
García‐Domínguez, M. (2024) · Biomolecules · doi:10.3390/biom14080926 · Cited by 34
Global Prevalence and Impact of Rumination Syndrome
Josefsson, A., Hreinsson, J. P., Simrén, M., Tack, J. F., Bangdiwala, S. I., Sperber, A. D., Palsson, O. S., & Törnblom, H. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.11.008 · Cited by 34
Understanding the Impact of Fibromyalgia on Men: Findings From a Nationwide Survey
Muraleetharan, D., Fadich, A., Stephenson, C., & Garney, W. R. (2018) · American Journal of Men s Health · doi:10.1177/1557988317753242 · Cited by 33
“However, a 2017 systematic review and meta-analysis that looked at the FM prevalence, or all individuals living with FM, in the world population identified approximately 3.98% of women with the disease, with men following closely behind at 2.40% ranging up to 4.80% (Heidari et al., 2017).”
BackgroundInfluentialBruun, K. D., Christensen, R., Amris, K., Vægter, H. B., Blichfeldt‐Eckhardt, M. R., Bye-Møller, L., Holsgaard‐Larsen, A., & Toft, P. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00278-3 · Cited by 33
Research in Mindfulness Interventions for Patients With Fibromyalgia: A Critical Review
Leça, S., & Tavares, I. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.920271 · Cited by 29
Salari, N., Hayati, A., Kazeminia, M., Rahmani, A., Mohammadi, M., Fatahian, R., & Shohaimi, S. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05689-y · Cited by 32
“9% in dialysis patients and 80% in patients with Behcet syndrome [2].”
BackgroundPérez‐Aranda, A., D’Amico, F., Feliu‐Soler, A., McCracken, L. M., Peñarrubia‐María, M. T., Andrés‐Rodríguez, L., Angarita‐Osorio, N., Knapp, M. R. J., García‐Campayo, J., & Luciano, J. V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071068 · Cited by 29
“It is usually diagnosed in women aged between 30 and 50 years old and has an estimated prevalence of around 2% in the general population [2,3].”
BackgroundHazrati, E., Eftekhar, S. P., Mosaed, R., Dini, S. S., & Namazi, M. (2024) · Molecular Pain · doi:10.1177/17448069241275097 · Cited by 34
Sodhi, N., Moore, T., Vakharia, R. M., Leung, P., Seyler, T. M., Roche, M. W., & Mont, M. A. (2019) · The Journal of Arthroplasty · doi:10.1016/j.arth.2019.04.023 · Cited by 27
Pedro Zitko, M., Bilbeny, N., Balmaceda, C., Abbott, T., Carcamo, C., & Espinoza, M. (2021) · BMC Public Health · doi:10.1186/s12889-021-10953-z · Cited by 29
“The prevalence of fibromyalgia obtained in our study was slightly higher than the pooled prevalence informed in a last available systematic review [33], although our number is included in the heterogeneity of estimations.”
BackgroundPrevalence of fibromyalgia syndrome in Saudi Arabia: a systematic review and meta-analysis
Bawazir, Y. M. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06821-z · Cited by 31
“In addition, the total prevalence in the general population of Eastern Mediterranean region, and the Western Pacific general population was 2.41% and 1.60% [6].”
BackgroundInfluentialVarallo, G., Piterà, P., Fontana, J. M., Gobbi, M., Arreghini, M., Giusti, E. M., Franceschini, C., Plazzi, G., Castelnuovo, G., & Capodaglio, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154324 · Cited by 25
Salm, D. C., Belmonte, L. A. O., Emer, A. A., Leonel, L. D. S., de Brito, R. N., da Rocha, C. C., Martins, T. C., dos Reis, D. C., Moro, A. R. P., Mazzardo‐Martins, L., et al. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577077 · Cited by 25
Macian, N., Dualé, C., Voute, M., Leray, V., Courrent, M., Bodé, P., Giron, F., Soule-Sonneville, S., Bernard, L., Joanny, F., et al. (2022) · Nutrients · doi:10.3390/nu14102088 · Cited by 28
“Fibromyalgia (FM) affects 2% of the general population, with a predominance in women [1].”
BackgroundVilarino, G. T., Branco, J. H. L., de Souza, L. C., & Andrade, A. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03205-5 · Cited by 28
Samartin-Veiga, N., González-Villar, A. J., Pidal-Miranda, M., Vázquez-Millán, A., & Carrillo‐de‐la‐Peña, M. T. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03106-1 · Cited by 28
Cabral, C. M. N., Miyamoto, G. C., Franco, K. F. M., & Bosmans, J. E. (2021) · Pain · doi:10.1097/j.pain.0000000000002233 · Cited by 24
CNS imaging characteristics in fibromyalgia patients with and without peripheral nerve involvement
Aster, H.-C., Evdokimov, D., Braun, A., Üçeyler, N., Kampf, T., Pham, M., Homola, G. A., & Sommer, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-10489-1 · Cited by 23
“Comparison of the noPNS and PNS subgroups showed (1) lower volumes in the bilateral pericalcarine cortex in the PNS group, (2) lower FA in the left posterior limb of internal capsule and in the posterior thalamic radiation in the PNS group and (3) a hyperconnectivity cluster between the bilateral inferior frontal gyri…”
BackgroundResultAmris, K., Ibsen, R., Duhn, P. H., Olsen, J., Lolk, K., Kjellberg, J., & Kristensen, L. E. (2024) · RMD Open · doi:10.1136/rmdopen-2023-003904 · Cited by 25
Mease, P. J., Reed, G. W., Ogdie, A., Pappas, D. A., & Kremer, J. M. (2024) · Arthritis Care & Research · doi:10.1002/acr.25358 · Cited by 25
Sundermann, B., Nayyeri, M. D., Pfleiderer, B., Stahlberg, K., Jünke, L., Baie, L., Dieckmann, R., Liem, D., Happe, T., & Burgmer, M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14558 · Cited by 23
The role of mind body interventions in the treatment of irritable bowel syndrome and fibromyalgia
Islam, Z., D’Silva, A., Raman, M., & Nasser, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1076763 · Cited by 26
“1) from a systematic review (n = 30 studies) and meta-analysis (n = 65 studies), likely as a consequence of differing study designs (24, 25).”
BackgroundOsteopathic medicine for fibromyalgia: a sham-controlled randomized clinical trial
Coste, J., Medkour, T., Maigne, J.-Y., Pérez, M., Laroche, F., & Perrot, S. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211009017 · Cited by 22
Huang, M., Magni, N., & Rice, D. A. (2021) · Journal of Pain · doi:10.1016/j.jpain.2021.04.001 · Cited by 23
Contreras‐Merino, A. M., Davydov, D. M., Galvez-Sánchez, C. M., & del Paso, G. A. R. (2022) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2022.03.001 · Cited by 22
Koçyiğit, B. F., & Akyol, A. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06385-8 · Cited by 21
“In addition to being primarily diagnosed, FMS can also occur secondary to various underlying disorders [20].”
BackgroundHeimfarth, L., dos Anjos, K. S., de Carvalho, Y. M. B. G., dos Santos, B. L., Serafini, M. R., Neto, A. G. D. C., Nunes, P. S., Filho, J. I. A. B., da Silva, S. P., Ribeiro, A. M., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116448 · Cited by 23
Chronic Pain Syndromes and Their Laryngeal Manifestations
Piersiala, K., Akst, L. M., Hillel, A. T., & Best, S. R. (2020) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2020.0530 · Cited by 20
Durán, J., Tejos‐Bravo, M., Vicente Cid, O., Catterina Ferreccio, R., & Calvo, M. (2023) · Pain · doi:10.1097/j.pain.0000000000002886 · Cited by 27
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review
Neelapala, Y. V. R., Mercuri, D., Macedo, L. G., Hanna, S., Kobsar, D., & Carlesso, L. C. (2023) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x231182894 · Cited by 20
Antunes, M. D., Loures, F. C. N. D. R., de Souza, I. M. B., Cruz, A. T., Januário, P. D. O., Pinheiro, M. M. L. S., Schmitt, A. C. B., Frutos‐Bernal, E., Nogueras, A. M. M., & Marques, A. P. (2023) · Trials · doi:10.1186/s13063-023-07588-3 · Cited by 19
“Studies also point to the presence of fibromyalgia in men [4–6].”
BackgroundLaden, B. F., Bresee, C. J., Hoedt, A. M. D., Dallas, K. B., Scharfenberg, A., Saxena, R., Senechal, J. F., Barbour, K. E., Kim, J., Freedland, S. J., et al. (2021) · Urology · doi:10.1016/j.urology.2021.04.015 · Cited by 19
Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis
Shresher, N. M., Mohamed, A. E., & Elshahaly, M. H. (2019) · Rheumatology International · doi:10.1007/s00296-019-04403-8 · Cited by 18
Tarar, Z. I., Farooq, U., Nawaz, A., Gandhi, M. H., Ghouri, Y. A., Bhatt, A., & Cash, B. D. (2023) · Biomedicines · doi:10.3390/biomedicines11102594 · Cited by 22
Pérez-Aranda, A., Barceló-Soler, A., Andrés-Rodríguez, L., Peñarrubia-María, M. T., Tuccillo, R., Borraz-Estruch, G., García-Campayo, J., Feliu-Soler, A., & Luciano, J. V. (2017) · Mindfulness & Compassion · doi:10.1016/j.mincom.2017.10.002 · Cited by 17
Hladkykh, F. V., Liadova, T., Matvieienko, M. S., Komorovsky, R., Smiyan, S., & Student, V. (2026) · Journal of Pain Research · doi:10.2147/jpr.s571311 · Cited by 22
Zahid, M., Ünal, E., Işık, Ö. Ö., Öksüz, S., Karakaya, J., & Çefle, A. (2022) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14325 · Cited by 17
Lozano-Plata, L. I., Vega‐Morales, D., Esquivel‐Valerio, J. A., Garza‐Elizondo, M. A., Galarza-Delgado, D. Á., Silva-Luna, K., Serna‐Peña, G., Sifuentes-Ramírez, J., Guerra, A. D. J. G., & de Rivera, R. D.-N. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05640-8 · Cited by 17
Koçyiğit, B. F., & Akyol, A. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06279-9 · Cited by 17
“It is remarkable that these results are higher than the literature data [16, 17].”
ResultSerrat, M., Sanabria‐Mazo, J. P., García-Troiteiro, E., Fontcuberta, A., Canedo, C. M., Almirall, M., Feliu‐Soler, A., Méndez-Ulrich, J. L., Sanz, A., & Luciano, J. V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020634 · Cited by 18
A behavioral and brain imaging dataset with focus on emotion regulation of women with fibromyalgia
Balducci, T., Rasgado‐Toledo, J., Valencia, A., van Tol, M., Aleman, A., & Garza‐Villarreal, E. A. (2022) · Scientific Data · doi:10.1038/s41597-022-01677-9 · Cited by 17
“The order of the sequences was: (1) resting state (rs-fMRI), (2) T1-weighted (T1w), (3) T2-weighted (T2w), (4) task (task-fMRI).”
BackgroundMethodInfluentialFibromyalgia: Centralized Pain Processing and Neuroimaging
Richard, J. Y., Hurley, R. A., & Taber, K. H. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19050107 · Cited by 17
Abnormal functional neurocircuitry underpinning emotional processing in fibromyalgia
Balducci, T., Garza‐Villarreal, E. A., Valencia, A., Aleman, A., & van Tol, M. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01578-x · Cited by 16
“Fibromyalgia is a clinical syndrome that mainly affects women [1], characterized by a chronic presence of widespread pain, accompanied by a conglomerate of physical and psychological symptoms.”
BackgroundHaddad, H. W., Mallepalli, N. R., Scheinuk, J. E., Bhargava, P., Cornett, E. M., Urits, I., & Kaye, A. D. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00266-9 · Cited by 17
Rivera, F. A., Munipalli, B., Allman, M. E., Hodge, D. O., Wieczorek, M. A., Wang, B. X., Abril, A., Perlman, A. I., Knight, D. R. T., & Bruce, B. K. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1301944 · Cited by 15
“FM can affect individuals of all ages, but it is more commonly diagnosed in middle aged adults (30–50-year-old) (1, 2).”
BackgroundZhang, X., Kanter, K. N., Chen, J., Kim, S., Wang, Y., Adeyemi, C., O’Buckley, S. C., & Nackley, A. G. (2019) · Pain · doi:10.1097/j.pain.0000000000001734 · Cited by 15
Woodbury, A., Krishnamurthy, V., Gebre, M., Napadow, V., Bicknese, C., Liu, M., Lukemire, J., Kalangara, J. P., Cui, X., Guo, Y., et al. (2020) · Pain Medicine · doi:10.1093/pm/pnaa317 · Cited by 16
“Fibromyalgia is a chronic pain syndrome that consists of chronic widespread pain, decreased physical function, fatigue, psychoemotional and sleep disturbances, and various somatic complaints and affects approximately 8 million people in the United States [1].”
BackgroundBrown, T. J., Hammond, A., Ching, A., & Parker, J. L. (2023) · Musculoskeletal Care · doi:10.1002/msc.1760 · Cited by 15
Prevalence of fibromyalgia in physicians in training: a cross-sectional study
Omair, M. A., Alobud, S., Al-Bogami, M. H., Dabbagh, R., Altaymani, Y. K., Alsultan, N., Alhazzani, A. A., & Omair, M. A. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4313-x · Cited by 17
Partridge, S., Quadt, L., Bolton, M. J., Eccles, J., Thompson, C., Colasanti, A., Bremner, S. A., Jones, C. I., Bruun, K. D., & van Marwijk, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15638 · Cited by 14
Henley, P. P., Martins, T., & Zamani, R. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20247185 · Cited by 14
“Fibromyalgia prevalence is unknown; however, it has been estimated to be around 2% [24].”
BackgroundProteomics in Patients with Fibromyalgia Syndrome: A Systematic Review of Observational Studies
Gkouvi, A., Tsiogkas, S. G., Bogdanos, D. P., Gika, H., Goulis, D. G., & Grammatikopoulou, M. G. (2024) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01244-4 · Cited by 16
“For example, 14.8% of patients with type 2 diabetes mellitus and 80% of those with Behçet’s disease are diagnosed with FMS [4, 5].”
BackgroundInfluentialA Patient-Narrative Video Approach to Teaching Fibromyalgia
Leeds, F. S., Sommer, E. M., Andrasik, W. J., Atwa, K. M., & Crawford, T. N. (2020) · Journal of Medical Education and Curricular Development · doi:10.1177/2382120520947068 · Cited by 14
Samman, A. A., Bokhari, R. A., Idris, S., Bantan, R., Margushi, R., Lary, S., Sait, R. M., & Bawazir, Y. M. (2021) · Cureus · doi:10.7759/cureus.12670 · Cited by 14
“The diagnosis is primarily based on chronic pain that is generalized with tenderness at the time of the physical exam, along with fatigue, sleep problems, notable cognitive dysfunction, mood changes, and headaches [4].”
BackgroundPatel, A., Alsaffar, A. M., Sharma, M., Masiak, A., & Zdrojewski, Z. (2021) · Reumatologia/Rheumatology · doi:10.5114/reum.2021.106908 · Cited by 16
Treatment preferences in fibromyalgia patients: A cross‐sectional web‐based survey
Valentini, E., Fetter, E., & Orbell, S. (2020) · European Journal of Pain · doi:10.1002/ejp.1570 · Cited by 14
“Women are twice as likely to be diagnosed with the FM syndrome compared to men, with the most common age for the onset of the diagnosis between the ages of 25 and 55 (Heidari et al., 2017).”
BackgroundPsychometric properties of Turkish version of Jenkins sleep scale in fibromyalgia syndrome
Ünal-Ulutatar, Ç., & Özsoy-Ünübol, T. (2020) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-020-0123-3 · Cited by 14
Agarwal, A., Emary, P. C., Gallo, L., Oparin, Y., Shin, S. H., Fitzcharles, M., Adachi, J. D., Cooper, M. D., Craigie, S., Rai, A., et al. (2024) · Medicine · doi:10.1097/md.0000000000039109 · Cited by 17
A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System
García‐Domínguez, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010165 · Cited by 13
Le, T. P., Tzeng, Y., Muo, C., Ting, H., Sung, F., Lee, S., & Teng, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238502 · Cited by 14
“Patients with FM often have nonspecific symptoms and are at increased risk of many comorbidities and disorders [4].”
BackgroundFibromyalgia in Health Care Worker During COVID-19 Outbreak in Saudi Arabia
Alenzi, F., Alhamal, S., Alramadhan, M., Altaroti, A., Siddiqui, I. A., & Aljanobi, G. A. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.693159 · Cited by 14
“(29), in the general population, the pooled prevalence of FM among men and women was 0.”
BackgroundCentral sensitization and its relationship with health profile in Behçet’s disease
Ayar, K., Ökmen, B. M., Altan, L., & ÖZTÜRK, E. K. (2020) · Modern Rheumatology · doi:10.1080/14397595.2020.1780076 · Cited by 13
Climent‐Sanz, C., Gea‐Sánchez, M., Fernández‐Lago, H., Mateos, J. T., Rubí‐Carnacea, F., & Briones‐Vozmediano, E. (2021) · Journal of Advanced Nursing · doi:10.1111/jan.14977 · Cited by 14
González-Álvarez, M. E., Riquelme-Aguado, V., Rossettini, G., Fernández‐Carnero, J., & Villafañe, J. H. (2024) · Life · doi:10.3390/life15010040 · Cited by 15
“Due to the gender prevalence of fibromyalgia, more than 9 out of 10 patients are women [33,34], and only female patients participated in this study.”
Redondo, J. R., Fontecha, P. D. D. C., de Miquel, C. A., Almirall, M., Fernández, B. C., Ojeda, C. C., Cruz, A. C., Montesó‐Curto, P., Palao, Á., Calvo, E. T., et al. (2021) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2021.02.002 · Cited by 12
Huang, M., Yen, H., Lin, C., Lee, Y., Sun, M.-F., & Wu, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239703 · Cited by 13
Metadata
- Authors
- Heidari, F., Afshari, M., & Moosazadeh, M.
- Affiliations
- Mazandaran University of Medical Sciences (IR)
- Zabol University of Medical Sciences (IR)
- Corresponding author
- Moosazadeh, Mahmood
- Venue
- Rheumatology International
- Published
- 2017-04-26
- Volume
- 37
- Issue
- 9
- Pages
- 1527-1539
- ISSN
- 0172-8172 (ISSN-L)
- 1437-160X
- OpenAlex
- W2609172362
- Cited by
- 432
- References
- 76
- Citations by year
- 2026: 61 · 2025: 68 · 2024: 69 · 2023: 51 · 2022: 53 · 2021: 58 · 2020: 34 · 2019: 24 · 2018: 8 · 2017: 6
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Rheumatology International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Myofascial pain diagnosis and treatment
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- fibromyalgia, prevalence, general population, sex differences, hemodialysis patients, Behçet's disease, irritable bowel syndrome, type 2 diabetes, comorbidities, rheumatology patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Fibromyalgia, Humans, Male, Middle Aged, Risk Factors, Comorbidity, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review